Liangren Zhang

7.7k total citations
236 papers, 6.2k citations indexed

About

Liangren Zhang is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Liangren Zhang has authored 236 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Molecular Biology, 55 papers in Organic Chemistry and 38 papers in Physiology. Recurrent topics in Liangren Zhang's work include Calcium signaling and nucleotide metabolism (37 papers), Computational Drug Discovery Methods (28 papers) and DNA and Nucleic Acid Chemistry (23 papers). Liangren Zhang is often cited by papers focused on Calcium signaling and nucleotide metabolism (37 papers), Computational Drug Discovery Methods (28 papers) and DNA and Nucleic Acid Chemistry (23 papers). Liangren Zhang collaborates with scholars based in China, Hong Kong and United States. Liangren Zhang's co-authors include Ning Jiao, Zhenming Liu, Lihe Zhang, Hongwei Jin, Chun Zhang, Wang Zhou, Zejun Xu, Yijin Su, Zhenjun Yang and Qiang Zhang and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Liangren Zhang

229 papers receiving 6.1k citations

Peers

Countries citing papers authored by Liangren Zhang

Since Specialization

Citations

This map shows the geographic impact of Liangren Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangren Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangren Zhang more than expected).

Fields of papers citing papers by Liangren Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangren Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangren Zhang. The network helps show where Liangren Zhang may publish in the future.

Co-authorship network of co-authors of Liangren Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Liangren Zhang. A scholar is included among the top collaborators of Liangren Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangren Zhang. Liangren Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Scaffold hopping-driven optimization for the identification of NLRP3 inhibitors as potential gout therapeutics 2024 ·European Journal of Medicinal Chemistry ·(unknown), Weiping Lyu, Jie Yu, Yanming Chen, Siyu Xiu, Xiangyu Zhang, Liangren Zhang, Zhenming Liu	1
2	GPX4 allosteric activators inhibit ferroptosis and exert myocardial protection in doxorubicin-induced myocardial injury mouse model 2024 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Qian Wang, (unknown), (unknown), Zhenming Liu, Liangren Zhang	3
3	Novel mechanistic insights – A brand new Era for anti-HBV drugs 2024 ·European Journal of Medicinal Chemistry ·Weiping Lyu, (unknown), (unknown), (unknown), Shi Cheng, Kangchen Zhao, (unknown), Ruohan Yu, Huiying Zhang, Xiaonan Zhou, (unknown), Liangren Zhang, Xiaoqian Wang, (unknown), Zhenming Liu	6
4	Machine learning- and structure-based discovery of a novel chemotype as FXR agonists for potential treatment of nonalcoholic fatty liver disease 2023 ·European Journal of Medicinal Chemistry ·Qin Tong, Xuefeng Gao, Lei Lei, Jing Feng, Wenxuan Zhang, (unknown), Zhufang Shen, Zhenming Liu, Yi Huan, Song Wu, Jie Xia, Liangren Zhang	8
5	Structure-activity relationship study of RSL3-based GPX4 degraders and its potential noncovalent optimization 2023 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Han Wang, (unknown), Guoquan Liu, Zhenming Liu, Liangren Zhang, Ping Xu	30
6	NSD3: Advances in cancer therapeutic potential and inhibitors research 2023 ·European Journal of Medicinal Chemistry ·Siyu Xiu, Xiaowei Chi, Zhenyu Jia, Shi Cheng, Xiangyu Zhang, Qi Li, (unknown), Liangren Zhang, Zhenming Liu	10
7	Identification of a small chemical as a lysosomal calcium mobilizer and characterization of its ability to inhibit autophagy and viral infection 2023 ·FEBS Journal ·Kehui Zhang, Lihong Huang, Yang Cai, Yi Zhong, (unknown), Fei Gao, Liang Zhang, Qi Li, Zhenming Liu, Rongxin Zhang, Liangren Zhang, Jianbo Yue	2
8	Structural optimization and biological evaluation of 1-adamantylcarbonyl-4-phenylpiperazine derivatives as FXR agonists for NAFLD 2022 ·European Journal of Medicinal Chemistry ·Qin Tong, Xuefeng Gao, Lei Lei, Wenxuan Zhang, Jing Feng, (unknown), Zhufang Shen, Zhenming Liu, Huan Yi, Song Wu, Jie Xia, Liangren Zhang	10
9	Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main protease 2022 ·European Journal of Medicinal Chemistry ·Xiaodong Dou, Qi Sun, Guofeng Xu, Yameng Liu, Caifang Zhang, (unknown), (unknown), Zheng Guo, (unknown), (unknown), Xinyi Zhao, Chen Wang, (unknown), Song Song, Liangren Zhang, Zhenming Liu, Luhua Lai, Ning Jiao	8
10	Engineering a bacterial sialyltransferase for di-sialylation of a therapeutic antibody 2020 ·Organic & Biomolecular Chemistry ·(unknown), Yue Wang, (unknown), Xiaodong Dou, Zhenming Liu, Liangren Zhang, Xin‐Shan Ye	3
11	Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases 2019 ·Journal of Medicinal Chemistry ·Xiaodong Dou, (unknown), Yibo Li, Lan Jiang, Yanxing Wang, Hongwei Jin, Ning Jiao, Lihe Zhang, Liangren Zhang, Zhenming Liu	46
12	Rational Design and Identification of Small‐Molecule Allosteric Inhibitors of CD38 2019 ·ChemBioChem ·Lixin Yang, Ting Li, (unknown), Yang‐Chang Wu, (unknown), Hongwei Jin, Zhenming Liu, Yong Zhao, Liangren Zhang, Hon Cheung Lee, Lihe Zhang	6
13	Design, synthesis, and biological evaluation of imidazo[1,2- b ]pyridazine derivatives as mTOR inhibitors 2017 ·European Journal of Medicinal Chemistry ·Beibei Mao, (unknown), (unknown), Liangren Zhang, Lihe Zhang, (unknown), (unknown)	28
14	Cheminformatics analysis of the Chinese National Compound Library of Peking University 2016 ·Journal of Chinese Pharmaceutical Sciences ·Jianxing Hu, (unknown), Zhenming Liu, Liangren Zhang	2
15	Comparative Analysis of Pharmacophore Features and Quantitative Structure–Activity Relationships for CD38 Covalent and Non‐covalent Inhibitors 2015 ·Chemical Biology & Drug Design ·Shuang Zhang, (unknown), Liangren Zhang, Lihe Zhang, Zhenming Liu	19
16	Synthesis and Calcium Mobilization Activity of cADPR Analogues Which Integrate Nucleobase, Northern and Southern Ribose Modifications 2012 ·Molecules ·Yue Zhou, Peilin Yu, Hongwei Jin, Zhenjun Yang, Jianbo Yue, Liangren Zhang, Lihe Zhang, (unknown), (unknown)	7
17	Efficient synthesis of 8-oxa-bicyclo[3.2.1]octane derivatives from d-arabinose 2007 ·Tetrahedron Asymmetry ·Yi Liu, (unknown), Zhenjun Yang, Liangren Zhang, Lihe Zhang, (unknown), (unknown)	4
18	Three-dimensional structure of HIV-1 VIF constructed by comparative modeling and the function characterization analyzed by molecular dynamics simulation 2007 ·Organic & Biomolecular Chemistry ·(unknown), Zhenming Liu, Hongwei Jin, Xianghui Yu, Liangren Zhang, Lihe Zhang, (unknown), (unknown)	23
19	Amplification and propagation of pacemaker Ca2+ signals by cyclic ADP-ribose and the type 3 ryanodine receptor in T cells 2004 ·Journal of Cell Science ·(unknown), Matthias F. Langhorst, (unknown), Xianfeng Gu, Lijun Huang, Zhenjun Yang, Liangren Zhang, Steven Mills, Lihe Zhang, Barry V. L. Potter, Andreas H. Guse	33
20	Synthesis and biological activities of 5′-ethylenic and acetylenic modified l-nucleosides and isonucleosides 2004 ·Tetrahedron ·(unknown), Xiaoda Yang, Liangren Zhang, Zhenjun Yang, Lihe Zhang	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact